Chuv Lausanne

Lausanne CH-1011

0 studies enrolling now · 7 studies all time

What they study most

C3 Glomerulonephritis, C3 Glomerulopathy, C3G, Cerebrovascular Accident, Chronic Kidney Disease, Complement 3 Glomerulonephritis, Complement 3 Glomerulopathy, Complement 3 Glomerulopathy (C3G), DDD, Dense Deposit Disease, Genetic Diseases, Inborn, Genetic Diseases, X-Linked

Studies at this site

• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Completed
• Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry — Completed
• An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy — Stopped early
• Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) — Completed
• BRAIN (Biomarker Rapid Assessment of Ischemic iNjury) — Completed
• Study of Phosphate Levels in Patients With Chronic Kidney Disease — Completed
• Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients — Completed